Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Simon

Showing results (91-100 of 167) with videos related to

Pageof 17
Sort By:
Lab on a Chip|February 20, 2026
Correction: Reversible and reusable compartmentalized thermoplastic chip for coculture of dorsal root ganglion neuronsSolène Moreau, Raul Flores-Berdines, Anne Simon, et al.
AIDS (London, England)|November 2, 2013
NKp44L expression on CD4+ T cells is associated with impaired immunological recovery in HIV-infected patients under highly active antiretroviral therapyAlexis Sennepin, Florence Baychelier, Amélie Guihot, et al.
Lab on a Chip|November 19, 2025
Reversible and reusable compartmentalized thermoplastic chip for coculture of dorsal root ganglion neuronsSolène Moreau, Raul Flores-Berdines, Anne Simon, et al.
Journal of Medical Virology|March 25, 2008
Structural effects of amino acid variations between B and CRF02-AG HIV-1 integrasesIsabelle Malet, Cathia Soulie, Luba Tchertanov, et al.
Plos One|November 11, 2011
Divalent cations and redox conditions regulate the molecular structure and function of visinin-like protein-1Conan K Wang, Anne Simon, Christian M Jessen, et al.
The Journal of Antimicrobial Chemotherapy|April 30, 2015
Low-level HIV-1 viraemia in patients on HAART: risk factors and management in clinical practiceMarc Wirden, Eve Todesco, Marc-Antoine Valantin, et al.
Journal of Clinical Microbiology|June 7, 2003
Interruption of nonnucleoside reverse transcriptase inhibitor (NNRTI) therapy for 2 months has no effect on levels of human immunodeficiency virus type 1 in plasma of patients harboring viruses with mutations associated with resistance to NNRTIsMarc Wirden, Anne Simon, Luminita Schneider, et al.
Antiviral Therapy|May 17, 2007
Genetic diversity and drug resistance mutations in HIV type 1 from untreated patients in Bamako, MaliAnne Derache, Ousmane Traore, Victoria Koita, et al.
AIDS (London, England)|June 15, 2012
E138K and M184I mutations in HIV-1 reverse transcriptase coemerge as a result of APOBEC3 editing in the absence of drug exposureSlim Fourati, Isabelle Malet, Sidonie Lambert, et al.
AIDS (London, England)|June 27, 2008
Risk factors for bacterial infections in HIV/hepatitis C virus-coinfected patients treated with interferon plus ribavirinFirouzé Bani-Sadr, Isabelle Goderel, Nathanael Lapidus, et al.
Pageof 17

Showing results (91-100 of 167) with videos related to

Sort By:
Pageof 17
Lab on a Chip|February 20, 2026
Correction: Reversible and reusable compartmentalized thermoplastic chip for coculture of dorsal root ganglion neuronsSolène Moreau, Raul Flores-Berdines, Anne Simon, et al.
AIDS (London, England)|November 2, 2013
NKp44L expression on CD4+ T cells is associated with impaired immunological recovery in HIV-infected patients under highly active antiretroviral therapyAlexis Sennepin, Florence Baychelier, Amélie Guihot, et al.
Lab on a Chip|November 19, 2025
Reversible and reusable compartmentalized thermoplastic chip for coculture of dorsal root ganglion neuronsSolène Moreau, Raul Flores-Berdines, Anne Simon, et al.
Journal of Medical Virology|March 25, 2008
Structural effects of amino acid variations between B and CRF02-AG HIV-1 integrasesIsabelle Malet, Cathia Soulie, Luba Tchertanov, et al.
Plos One|November 11, 2011
Divalent cations and redox conditions regulate the molecular structure and function of visinin-like protein-1Conan K Wang, Anne Simon, Christian M Jessen, et al.
The Journal of Antimicrobial Chemotherapy|April 30, 2015
Low-level HIV-1 viraemia in patients on HAART: risk factors and management in clinical practiceMarc Wirden, Eve Todesco, Marc-Antoine Valantin, et al.
Journal of Clinical Microbiology|June 7, 2003
Interruption of nonnucleoside reverse transcriptase inhibitor (NNRTI) therapy for 2 months has no effect on levels of human immunodeficiency virus type 1 in plasma of patients harboring viruses with mutations associated with resistance to NNRTIsMarc Wirden, Anne Simon, Luminita Schneider, et al.
Antiviral Therapy|May 17, 2007
Genetic diversity and drug resistance mutations in HIV type 1 from untreated patients in Bamako, MaliAnne Derache, Ousmane Traore, Victoria Koita, et al.
AIDS (London, England)|June 15, 2012
E138K and M184I mutations in HIV-1 reverse transcriptase coemerge as a result of APOBEC3 editing in the absence of drug exposureSlim Fourati, Isabelle Malet, Sidonie Lambert, et al.
AIDS (London, England)|June 27, 2008
Risk factors for bacterial infections in HIV/hepatitis C virus-coinfected patients treated with interferon plus ribavirinFirouzé Bani-Sadr, Isabelle Goderel, Nathanael Lapidus, et al.
Pageof 17